HIV fusion and its inhibition in antiretroviral therapy

The end of the twentieth century saw dramatic improvements in the prognosis of HIV infection brought about by the introduction of new agents (the protease inhibitors and the non‐nucleoside reverse transcriptase inhibitors) and their use in highly active combinations. However, the durability of these...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Reviews in medical virology 2004-09, Vol.14 (5), p.321-337
Hauptverfasser:	Greenberg, Michael, Cammack, Nick, Salgo, Miklos, Smiley, Lynn
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Child Clinical Trials, Phase III as Topic HIV Envelope Protein gp41 - pharmacology HIV Envelope Protein gp41 - therapeutic use HIV Fusion Inhibitors - pharmacology HIV Fusion Inhibitors - therapeutic use HIV Infections - drug therapy HIV-1 - drug effects HIV-1 - physiology Humans Membrane Fusion - drug effects Peptide Fragments - pharmacology Peptide Fragments - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!